Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMN107 vs ANIDULAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMN107 vs ANIDULAFUNGIN: Safety Overview

Metric AMN107 ANIDULAFUNGIN
Total FAERS Reports 182 701
Deaths Reported 15 325
Death Rate 8.2% 46.4%
Hospitalizations 67 287
Average Patient Age 64.4 yrs 53.3 yrs
% Female Patients N/A 40.0%
FDA Approval Date N/A Feb 17, 2006
Manufacturer N/A Roerig
Route N/A INTRAVENOUS
Marketing Status N/A Prescription